Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederstatnews.com
STAT
Get the latest updates from STAT directly as they happen.
Follow now 229 followers
Latest posts
Last updated about 4 hours ago
STAT+: Updated: Tracking RFK Jr.’s promises to remake health in America
about 4 hours ago
Updated June 11, 2026 WASHINGTON — A pledge to “Make America Healthy...
An obesity drug deep-dive, and peptides move mainstream
about 8 hours ago
Can any of the new obesity medications in development stand out from...
RFK Jr. claims his calendar is publicly available. We’ve been trying to get it for a year
about 8 hours ago
WASHINGTON — Health secretary Robert F. Kennedy Jr. on Wednesday pointed to...
Drinking during pregnancy rose after 2020, new CDC data suggest
about 9 hours ago
New data released Thursday suggest the prevalence of drinking during pregnancy increased...
STAT+: AMA and lawmakers push back on AI care denials
about 9 hours ago
You’re reading the web edition of STAT’s Health Tech newsletter, our guide...
Nonprofit buys experimental cancer drug to maintain patient access
about 10 hours ago
In a rare move, nonprofit organization Blood Cancer United announced Thursday it...
Study highlights influence of socioeconomic status on children’s brain development
about 10 hours ago
During the first five years of life, more than half the calories...
STAT+: Abridge inks deals with Nvidia and Lilly
about 11 hours ago
NEW YORK — Health care AI company Abridge on Thursday announced new...
STAT+: A suspicious denial pattern in Medicare Advantage
about 13 hours ago
You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about...
STAT+: Novartis doubles down on molecular glue strategy
about 14 hours ago
Want to stay on top of the science and politics driving biotech...
STAT+: Pharmalittle: We’re reading about employer coverage of obesity drugs, another Sanofi setback, and more
about 15 hours ago
Top of the morning to you, and a fine one it is...
STAT+: Enliven Therapeutics’ leukemia drug shows promise in new study
about 16 hours ago
A targeted drug from Enliven Therapeutics induced molecular responses in nearly half...